← All Topics
Last Reviewed: October 26, 2026
🔬
What is R&D to Sales Ratio? Pharma Innovation Spend
#Innovation#R&D Spend#Pharmaceuticals#Product Pipeline
The Answer
R&D / Sales measures a pharmaceutical company's expenditure on Research & Development as a percentage of total annual revenue.
Why it Matters
In generic pharma, R&D spend represents the product pipeline. Low R&D limits future generic launches and restricts revenue growth.
Sentinel Insight
“R&D is the generic pipeline seed. A drop in R&D spend signals that the company is boosting current quarter margins at the expense of future growth.”
📊 How to Interpret
Ratio > 10%
Elite Innovator
Ratio 6% - 10%
Healthy Investment
Ratio 3% - 6%
Under-invested Core
Ratio < 3%
Pipeline Erosion Risk
In Risk Context
Pharma sector innovation index.
Detect risk early
Flagium tracks these signals across multiple quarters to help you avoid structurally weak companies before it reflects in price.
View generic sector R&D pipelines →🔍🔁 Related Topics
Flagium Risk Brief — every Saturday
📬 Flagium Risk Brief — 3 forensic anomalies investigated weekly
See a sample issue →